Get the Stockscreener App
8.26
1.23%
0.10
Pre-market:
8.30
0.04
+0.48%
Terns Pharmaceuticals Inc stock is traded at $8.26, with a volume of 1.03M.
It is up +1.23% in the last 24 hours and up +9.99% over the past month.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
See More
Previous Close:
$8.16
Open:
$8.08
24h Volume:
1.03M
Relative Volume:
0.79
Market Cap:
$722.84M
Revenue:
-
Net Income/Loss:
$-95.90M
P/E Ratio:
-6.2576
EPS:
-1.32
Net Cash Flow:
$-79.09M
1W Performance:
+6.31%
1M Performance:
+9.99%
6M Performance:
+150.30%
1Y Performance:
+20.41%
1-Day Range:
$8.055
$8.35
1-Week Range:
$7.65
$8.87
52-Week Range:
$1.865
$9.0316
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Name
Terns Pharmaceuticals Inc
Sector
Industry
Phone
650-525-5535 EXT.101
Address
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Compare TERN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
8.26 | 714.09M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-25 | Initiated | Truist | Buy |
| Sep-17-25 | Initiated | Barclays | Overweight |
| Sep-04-25 | Resumed | H.C. Wainwright | Neutral |
| Feb-28-25 | Initiated | William Blair | Mkt Perform |
| Oct-31-24 | Initiated | Oppenheimer | Outperform |
| Jun-22-23 | Initiated | Mizuho | Buy |
| Jun-07-23 | Initiated | Jefferies | Buy |
| May-31-23 | Initiated | ROTH MKM | Buy |
| May-08-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-14-23 | Initiated | JMP Securities | Mkt Outperform |
| Feb-07-23 | Initiated | UBS | Buy |
| Sep-12-22 | Initiated | H.C. Wainwright | Neutral |
| Sep-14-21 | Resumed | Goldman | Buy |
| Mar-02-21 | Initiated | Cowen | Outperform |
| Mar-02-21 | Initiated | Goldman | Buy |
| Mar-02-21 | Initiated | JP Morgan | Overweight |
View All
Terns Pharmaceuticals Inc Stock (TERN) Latest News
How hedge fund analytics apply to Terns Pharmaceuticals Inc. stockWeekly Investment Report & Long-Term Safe Return Strategies - newser.com
Should you hold or exit Terns Pharmaceuticals Inc. nowGap Up & Free Fast Entry Momentum Trade Alerts - newser.com
How Terns Pharmaceuticals Inc. stock reacts to Fed rate cutsMarket Sentiment Review & Technical Entry and Exit Alerts - newser.com
Is Terns Pharmaceuticals Inc. still worth holding after the dipMarket Weekly Review & Daily Risk Controlled Trade Plans - newser.com
Will Terns Pharmaceuticals Inc. stock recover after recent dropShare Buyback & Daily Profit Focused Screening - newser.com
Advanced analytics toolkit walkthrough for Terns Pharmaceuticals Inc.Portfolio Value Report & Real-Time Market Trend Scan - newser.com
What Wall Street predicts for Terns Pharmaceuticals Inc. stock priceM&A Rumor & Long-Term Safe Return Strategies - newser.com
Applying Wyckoff theory to Terns Pharmaceuticals Inc. stockEarnings Growth Summary & Safe Entry Trade Signal Reports - newser.com
What does recent volatility data suggest for Terns Pharmaceuticals Inc.Entry Point & Step-by-Step Swing Trade Plans - newser.com
Price momentum metrics for Terns Pharmaceuticals Inc. explainedWeekly Stock Analysis & Fast Momentum Stock Entry Tips - newser.com
Terns Pharmaceuticals Inc Stock Analysis and ForecastSwing Trading Watchlist & Today’s Picks, Tomorrow’s Winners - earlytimes.in
How sentiment analysis helps forecast Terns Pharmaceuticals Inc.Market Performance Recap & High Accuracy Swing Entry Alerts - newser.com
Combining price and volume data for Terns Pharmaceuticals Inc.2025 Short Interest & Advanced Swing Trade Entry Plans - newser.com
Sector ETF performance correlation with Terns Pharmaceuticals Inc.2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Real time breakdown of Terns Pharmaceuticals Inc. stock performanceMarket Growth Report & Growth Oriented Trade Recommendations - newser.com
Terns Pharmaceuticals (TERN) Price Target Decreased by 11.67% to 16.14 - MSN
Will Terns Pharmaceuticals Inc. stock pay special dividendsPortfolio Return Summary & AI Forecasted Stock Moves - fcp.pa.gov.br
5 Under-the-Radar Biotech Stocks That Could Soar in 2026 - Yahoo Finance
Terns Pharmaceuticals Inc Stock (TERN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):